Abstract
Background: The use of chemotherapy in the peritoneum seeks to explore pharmacokinetic properties not possible with the use of systemic chemotherapy. PIPAC aims to optimize the distribution and depth of penetration of therapeutic agents into the peritoneal space. This form of application uses devices that aerosolize therapeutic substances using high injection pressure atomization. This article seeks to describe the feasibility in an animal model of a new modality of aerosolization of a therapeutic substance in the peritoneum using ultrasonic energy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.